Utah Medical Products, Inc. (FRA:UTM)

Utah Medical Products Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	164	153	201	277	341	321
Market Cap Growth	-20.98%	-24.18%	-27.18%	-18.96%	6.29%	27.96%
Enterprise Value	92	81	116	197	277	265
Last Close Price	50.00	47.60	56.28	74.49	-	-
PE Ratio	17.04	15.89	15.03	18.38	22.14	24.69
PS Ratio	4.99	4.65	5.10	6.09	6.98	7.44
PB Ratio	1.61	1.50	1.78	2.38	3.19	3.41
P/TBV Ratio	1.84	1.72	2.07	2.79	4.03	4.85
P/FCF Ratio	-	-	14.28	14.12	17.93	17.68
P/OCF Ratio	-	-	14.06	13.72	17.25	17.22
EV/Sales Ratio	2.83	2.47	2.94	4.34	5.65	6.14
EV/EBITDA Ratio	7.57	6.64	6.49	8.80	11.02	11.51
EV/EBIT Ratio	9.56	8.35	7.65	11.81	14.93	15.95
EV/FCF Ratio	-	-	8.24	10.06	14.53	14.58
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.02	0.02	0.01	0.01	0.02
Debt / FCF Ratio	-	-	0.02	0.01	0.02	0.02
Asset Turnover	0.31	0.31	0.32	0.39	0.44	0.43
Inventory Turnover	1.97	1.97	1.82	2.19	2.61	2.83
Quick Ratio	34.36	34.36	23.18	20.44	13.52	17.65
Current Ratio	37.62	37.62	25.64	22.56	15.09	19.54
Return on Equity (ROE)	9.54%	9.54%	11.29%	13.72%	14.88%	14.09%
Return on Assets (ROA)	5.82%	5.82%	7.62%	8.89%	10.33%	10.38%
Return on Invested Capital (ROIC)	26.84%	26.62%	36.84%	40.56%	36.65%	29.85%
Return on Capital Employed (ROCE)	9.50%	9.50%	13.20%	14.10%	16.80%	16.90%
Earnings Yield	5.87%	6.30%	6.65%	5.44%	4.52%	4.05%
FCF Yield	-	-	7.00%	7.08%	5.58%	5.66%
Dividend Yield	2.07%	2.19%	2.07%	1.44%	-	-
Payout Ratio	35.93%	-	30.70%	25.74%	19.20%	77.53%
Buyback Yield / Dilution	7.51%	7.51%	3.68%	0.16%	0.46%	0.33%
Total Shareholder Return	9.58%	9.71%	5.75%	1.60%	0.46%	0.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.